Coave Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Coave Therapeutics?

Coave Therapeutics has 16 investors including Seroba Life Sciences And Invus.

Q: How much funding has Coave Therapeutics raised to date?

Coave Therapeutics has raised obfuscated.

Overview

Coave Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Coave Therapeutics

CB Rank

55095

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Founded

obfuscation

Private

Series A

Paris, Ile-de-France, France

1-10

coavetx.com

Biotechnology

Genetics

Life Science

Neuroscience

Funding Rounds

Series A

OBF

obfuscation

Grant

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Christine Placet: Chief Executive Officer
Past Role: Trophos, Chief Executive Officer
Philippe Moullier: Chief Scientific Officer

Details

Legal Name

Coave Therapeutics

Also Known As

formerly known as Horama

Operating Status

Active

Company Type

For Profit

Founders

Denis Cayet, Guylène Le Meur, Michel Weber, Philippe Moullier

About the Company

Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.

Contact Email

contact@coavetx.com

Predictions & Insights

Growth Insight

See this Growth Insight

Coave Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

ALIGATER™ Platform

A platform that chemically modifies AAV capsids or lipid nanoparticles to improve gene therapy delivery to the central nervous system and eye.

CTx-PDE6b Gene Therapy

An AAV5-based gene therapy candidate for treating retinitis pigmentosa caused by bi-allelic mutations in the PDE6b gene.

Research & Development

Coave Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A
obfuscated obfuscation	Series A - Coave Therapeutics	9	obfuscated obfuscation	Bpifrance, Novo Holdings	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Seroba Life Sciences	—	Series A - Coave Therapeutics	—
Seroba Life Sciences	—	Series A - Coave Therapeutics	—
Seroba Life Sciences	—	Series A - Coave Therapeutics	—
Seroba Life Sciences	—	Series A - Coave Therapeutics	—
Seroba Life Sciences	—	Series A - Coave Therapeutics	—